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Abstract
Background: In 1999, South Africa became the first African country to approve commercial production of
subsistence genetically modified (GM) maize. The introduction of GM crop technology is often met with skepticism
by stakeholders including farmers. The involvement of the private sector in this process can further breed mistrust
or misperceptions. To examine these issues more closely, the objective of this case study was to understand the
role of trust in the public-private partnership (PPP) arrangement involved in the development of Bacillus
thuringiensis (Bt) maize in South Africa.
Methods: We conducted semi-structured, face-to-face interviews to obtain stakeholders’ understanding of trust in
general as well as in the context of agricultural biotechnology (agbiotech) PPPs. A thematic analysis of the
interview transcripts, documents, reports and research articles was conducted to generate insights into the
challenges to, and practices for, building trust among the partners and with the public.
Results: The findings of this study are organized into four main lessons on trust building. First, as the end users of
GM technology, farmers must be engaged from the start of the project through field demonstrations and
educational activities. Second, an effective technology (i.e., the seed) is key to the success of an agbiotech PPP.
Third, open communication and full disclosure between private sector companies and government regulatory
bodies will build trust and facilitate the regulatory processes. Fourth, enforcing good agronomic practices,
including appropriate management of the refuge areas, will serve the interests of both the farmers and the seed
companies.
Conclusions: Trust has proven to be a critical factor determining the success of the Bt maize project in South
Africa. Distrust of the private sector and of GM technology were cited as major barriers to building trust. The trust-
building practices described in this case study have often served to overcome these barriers; however, erosion of
trust was also present. The success of the project has been, and will continue to be, dependent upon the
concerted effort of the farmers, government, and private sector players in the establishment and maintenance of
trust.
Background
History of Bt maize in South Africa
One of the major challenges hindering the production of
maize, a staple food in South Africa, is the damage to
crops caused by maize stalk borers [1]. Studies have esti-
mated that the annual loss in maize due to the stalk
borer is about one million tonnes, which is valued at
approximately US $2.7 billion [2]. In response to the
challenge posed by the stalk borer globally, scientists and
private companies began developing Bacillus thuringien-
sis (Bt) maize, a genetically-modified (GM) crop that is
resistant to stalk borer insect pests. Bt maize was first
approved for commercial production in South Africa in
1998. South Africa was in fact the first African country to
approve the commercial production of a GM subsistence
crop [3,4]. As of 2011, the adoption of biotech crops in
South Africa had reached 2.3 million hectares, 81%
(1.873 million hectares) of which was biotech maize [5].
The increase in hectarage may be attributable to a yield
advantage of 11.03% and 10.60% on irrigated farms and
dry land, respectively, when using Bt maize as opposed to
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conventional maize [4]. This impact is expected to be
even greater where the stem borer infestation is higher.
The production of Bt maize, like that of other GM
crops, was fuelled by commercial interests of private
companies such that GM crops were used primarily for
commercial farming [3]. Initial efforts at commercializing
Bt maize was spearheaded by two private companies:
Monsanto Company and Syngenta [2]. The genetically
modified organisms (GMO) Act was passed in 1997,
allowing active GM work in South Africa to commence.
Prior to that, the South African Committee for Genetic
Experimentation (SAGENE), an association of industry
experts, developed guidelines that served as a watchdog
and advisory body to scientists, industry and government
on matters of agricultural biotechnology (agbiotech) [6].
Monsanto is the key player in the Bt maize industry in
South Africa. Monsanto’s Bt genes are found in the com-
pany’s own hybrids and, at the same time, it has licensed
the technologies to Pioneer Hibred and Pannar Seed com-
panies, which have introgressed the genes into their own
hybrids [4]. Monsanto’s monopoly on Bt maize in South
Africa ended in 2003, which is when Syngenta’s Bt maize
was approved by the Department of Agriculture [4].
Syngenta’s Bt genes – introgressed with maize varieties to
confer resistance to the maize stalk borer – have been
commercialized in a joint venture with Seedco Seed Com-
pany. Dow Chemicals is another company that has tried
its Bt genes in South Africa, in collaboration with Pioneer
Hibred South Africa [4].
In addition to the private sector actors involved, two
not-for-profit organizations were integral to the success of
commercializing Bt maize in South Africa: the Agricultural
Research Council (ARC) and AfricaBio. The ARC is the
largest agricultural research organization in South Africa
[7]. AfricaBio is a biotechnology stakeholders association
whose mandate is to share knowledge, information, and
awareness of biotechnology—including Bt maize—and its
proper management [8]. AfricaBio has supported many
promotional and community engagement initiatives, such
as the on-site demonstrations of Bt maize (see Additional
file 1 for the roles of the key collaborators/partners in the
Bt maize partnership in South Africa).
The institutions (private companies, government institu-
tions and others) engaged in Bt maize production in South
Africa are not linked through a typical or formal public-
private partnership (PPP) arrangement. Instead, this initia-
tive was driven by “a system of collaboration” comprised
of government actors, non-governmental organizations
(NGOs), and private sector companies. This system of col-
laboration was built upon a shared objective to reduce the
amount of maize crop yield lost due to the maize stem
borer. While there was no formal PPP in place throughout
the introduction of Bt maize in South Africa, the lessons
on trust building and collaboration drawn from this case
study are certainly generalizable to more formal agbiotech
PPPs.
Trust among partners and with the public has been
identified as an important element of successful PPPs [9].
Factors affecting the establishment, development, and
maintenance of trust in PPPs can either ensure or
compromise the success of agbiotech projects as a whole.
Trust is especially critical in agbiotech PPPs, as the intro-
duction of GM crops can often be contentious and
hindered by public mistrust in private sector involvement.
The involvement of the private sector in these PPPs can
often breed skepticism, as the public sector often perceives
the intentions of the private sector as suspect [10,11]. In
particular, a fear exists within the public sector that multi-
national biotechnology companies may seek to take advan-
tage of the resource-constrained nations in which they
operate PPPs [12]. In some cases, this distrust is met by
similar hesitations on the part of the private sector, which
views the public sector as slow, inefficient, and resistant to
new technologies [11]. These underlying issues form the
basis of this case study, which seeks to investigate existing
trust-building practices that may serve to overcome bar-
riers to trust in agbiotech PPPs.
This study constitutes one in a series of eight case stu-
dies investigating the role of trust in agbiotech PPPs and
the adoption of GM crops in sub-Saharan Africa. Trust is
important in agbiotech PPPs as its presence enables part-
ners to complete complex, long-term tasks and achieve
intended results [13,14].
The three specific goals of this series of case studies are
to: 1) describe trust-building practices in the develop-
ment of agbiotech projects; 2) describe the challenges
associated with trust building in PPPs; and 3) determine
what makes these practices effective or ineffective. This
particular study seeks to accomplish these goals by
describing and analyzing the trust-building practices
undertaken during the commercialization process of Bt
maize in South Africa. By identifying barriers to trust and
trust-enhancing practices, this study provides insight to
potential funders, researchers, farmers and others about
successful management of agbiotech PPPs.
Methods
A total of twelve individuals, drawn from both the public
and private sector, were interviewed for this study. They
included three small-scale and two large-scale maize farm-
ers; representatives from the private sector companies
Monsanto Company, Pioneer Hibred and Pannar; a repre-
sentative from the Council for Scientific and Industrial
Research (CSIR); and a representative from the Maize
Trust in South Africa.
Interviewees were identified by making a list of key indi-
viduals associated with the project based on the stake-
holders identified within the research protocol. This list
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was then populated further through snowball sampling.
Potential interviewees were sent an invitation, which con-
tained an explanation of the case study series, to partici-
pate in the interview. Those who consented to participate
were informed that the interview would be recorded,
transcribed and analyzed.
All the interviews took place in South Africa. They fol-
lowed a semi-structured, face-to-face format and each
lasted approximately one hour. The interview guide
included questions on the interviewees’ background, their
understanding of the project, and their interpretation of
the word trust. The interview explored perceptions of
trust among the partners and with the public, apparent
challenges to trust, and observed trust-building practices.
Finally, interviewees were asked for their suggestions on
how to improve agbiotech PPPs (see Additional file 2 for
sample questions from the interview guide).
The interviews were transcribed verbatim. The analysis
was performed by reading through the transcripts several
times, identifying trends and organizing them into major
themes. A literature review of academic articles and pro-
ject documents were also used in the writing of the report.
Research Ethics Board (REB) approval for this study was
obtained prior to conducting the case study from the
University Health Network, University of Toronto.
Results and discussion
Interviewees’ understanding of trust
Interviewees were asked to define trust and identify its
elements in the context of the Bt maize project in South
Africa. The key elements of trust, as identified by the par-
ticipants, were honesty and delivery of accurate informa-
tion in a timely manner. One interviewee defined trust as
“being honest, [and] sharing the right information at the
right time.” The interviewees described trust as being
very much determined experientially, pointing out that
trust is established if parties upheld their end of a deal
and delivered what they promised in a timely manner.
The interviewees also described trust as something that
had to be “earned over time.” Interviewees agreed that
trust was highly important in agbiotech PPPs, such as the
Bt maize project in South Africa. The findings of this
study are amalgamated into four key lessons on trust
building.
1. The technology is nothing without the farmer: engage
the end user early to ensure adoption of the technologies
The importance of building trust between farmers and
the private sector was articulated by some interviewees.
One representative from the private sector stated: You
have to build trust with your customers, which in our case
would be the farmers. Establishing and maintaining the
trust of farmers is essential for effective technology adop-
tion. And as one small-scale farmer stated, “if I didn’t
trust them [Africabio], I wouldn’t use their seed.” Building
trust with farmers has been shown to be achievable in a
number of ways in South Africa. The following are some
examples of practices that were used to build or erode
trust between farmers and the private sector in the con-
text of Bt maize in South Africa.
On-farm demonstrations One trust-building practice
identified by farmers was the use of on-farm demonstra-
tions that display the comparisons between Bt maize and
conventional maize in the field. In 2001, Monsanto sought
to engage with farmers by holding nine workshops across
South Africa to introduce over 3000 small-scale farmers to
Bt maize. Each farmer was given two bags of seed, one
each of Bt and conventional maize, to plant in their own
fields and compare the results [2]. This was one of
the first farmer engagement initiatives undertaken by
Monsanto after MON810, its GM event responsible for
insect resistance in Bt maize, was approved for use in
South Africa.
In a typical on-farm demonstration, seed companies or
distributors would provide both Bt and conventional
maize seeds for free to farmers to plant in a section of
their fields and compare crop performance and yield. In
addition, farmers were funded to host field days and invite
other farmers in the community to observe the differences
in performance at the demonstration sites. A farmer inter-
viewee, commenting on this, said: Yes, we did not pay.
They gave us [seeds] for free, and we planted the seeds.
And then they helped us with money to hoe the fields and
they come and they demonstrated the crops to other farm-
ers. This practice was employed in six demonstration plots
organized by AfricaBio between 2004 and 2005, which
showed that there were higher yields of maize due to
reduced stem borer infestations in Bt maize compared to
the non-Bt maize [3].
Interviewees who had taken part in demonstrations
described them as trust-building practices because of the
support that seed companies and AfricaBio would pro-
vide to farmers in terms of supplying seeds, compensat-
ing for labor, and educating them about the technology.
The primary goal of these on-farm demonstrations was
to foster trust among attending farmers, who were
able to judge first-hand the performance of Bt maize
compared to traditional maize. Many interviewees corro-
borated the effectiveness of this practice. However, inter-
viewees who had hosted on-farm demonstrations
recounted the erosion of trust that occurred when pro-
mises of financial compensation for their efforts were
withdrawn or left unfulfilled by the seed companies or
distributors. Some farmers reported that they would no
longer host field days and crop demonstrations due to
this lack of compensation. A small-scale farmer intervie-
wee said she “used to trust AfricaBio because of those
things they were doing” but when support in cash and
inputs dwindled, trust declined in a similar manner.
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Another farmer, making reference to the unreliability of
the government arm to supply inputs, said, “we [farmers]
don’t look too much to the government.”
Information dissemination and communication In
addition to on-farm demonstrations, several interviewees
felt that education and information dissemination about
Bt maize was an important trust-building practice that
could be achieved through a variety of avenues. One
interviewee stated: the biggest trust creation is generating
of science data, and then disseminating that data, and
putting it out there on the website, in leaflets and all that
so that the people understand what this is all about. One
government initiative that contributed to trust building
through education was the Public Understanding of Bio-
technology Program. As indicated by the senior manager
of the Technology Innovation Agency, this program
sought to “demystify this passive talk about what biotech-
nology is and provide factual evidence [on what biotech-
nology is capable of doing].” Another initiative was the
organization of regional study groups for farmers, the
purpose of which was information and knowledge sharing
among farmers.
One interviewee reflected on a positive trust-building
experience he had with AfricaBio when they invited him
to visit a university research laboratory to investigate the
process of Bt maize development and discuss any concerns
he had about the safety of the crop. The interviewee
appreciated that AfricaBio “did not play hide and seek”
about the technology but was willing to go to such an
extent to educate him about Bt maize. A farmer, com-
menting on this issue, stressed the need for “straightfor-
ward channels” to foster good communication and stated,
“If you have good communication, you can sort anything
out.”
2. The seed speaks for itself: delivering effective technology
builds trust between the industry and the farmers
Many interviewees emphasized the importance of an effec-
tive technology—in this case, an effective Bt maize seed—
in building trust. An interviewee representing a seed com-
pany and distributer said that the ability of the technology
to increase crop yields or reduce input costs is critical to
the success of Bt maize: If it was a technology that was not
providing benefits, they [farmers] would not be using it.
An interviewee from Monsanto attributed much of the
project’s success to “good genetics.” A large-scale commer-
cial farmer said: if you deliver a good product, you start to
build trust in that product. One small-scale farmer also
stated, “We’re building trust with the seed itself […]. The
performance of the seed is what you trust.” In the case of
the Bt maize project in South Africa, “the trust held in
place because the technology worked,” said an independent
researcher.
Guarantee that the Bt maize technology works and
honesty about its expected performance was cited as an
important trust-building practice by the private sector.
An interviewee from Monsanto described it thus: They
[farmers] need to trust you that the product they’re buying
from you will perform to expectation. In order to ensure
that realistic expectations are set, an interviewee from
another private seed company said, “we never misrepre-
sent whatever information that we share. So if a product
does not perform, we will say that it does not perform. If a
product does not perform, we will not take it to the
market.”
Despite these intentions, some interviewees described
instances when the performance of the Bt maize technol-
ogy did not meet their expectations. A few of these
instances created an opportunity to build trust as some
private companies took responsibility for the product fail-
ures and compensated the farmers affected. From one
farmer’s perspective, this “built a lot of trust. Because
that’s putting your money where your mouth is.” The
important lesson on trust that resulted from these cases
can be summarized by the following statement made by
an industry representative: The farmer knows that if there
is a problem that he could come back to the company to
say ‘listen, there is a problem’ and the company then
attends to the problem to resolve it.
In other cases, instances of product failure resulted in
the erosion of trust between the farmer and private seed
company when the latter failed to acknowledge or take
responsibility for the reported discrepancies. As one
farmer stated, “I don’t have any trust in your [the seed
company’s] product anymore. Because the technology is
failing under certain circumstances and [the seed com-
pany] don’t acknowledge that.”
The benefits of these trust-building practices can be sig-
nificant. In particular, once trust is established between
the farmers and the private companies, or between the
farmers and the seed companies, the power of word-of-
mouth within the farming community can be a great asset
to the private sector. As one small-scale farmer described,
“What I’ve done is to tell other farmers that I’m planting
this [Bt maize seed], [and that] this is going to help you to
get more yield.”
Acknowledging faults and taking responsibility in
instances of product failure was found to be an important
trust-building practice. The failure to do so, however, was
cited by some interviewees as a great barrier to trust build-
ing and in some instances led to ceasing use of the tech-
nology. Ensuring that Bt maize performs as expected and
is beneficial to the farmers is therefore important for the
adoption of the technology and the maintenance of trust
between farmers and the private sector.
3. Full disclosure facilitates regulatory processes and
enhances mutual trust between industry and government
The regulatory process for GM crops in South Africa is
outlined in the GMO Act, which was passed in 1997
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and came into effect in 1999 [15]. This Act created the
Executive Council, which is a decision-making body that
is responsible for approving or rejecting applications to
commercialize GM crops [15,16]. Monsanto’s MON810
was approved for commercial production by the Depart-
ment of Agriculture in 1998, upon the recommendation
of SAGENE. Syngenta’s Bt maize was likewise approved
in 2003 [4]. In order to build trust during the regulatory
approval process, it is important that both the applicant
and the regulator fully disclose all relevant information
throughout the process.
On the government side, it is important to clarify the
requirements for regulatory approval and communicate
them to the private companies. As stated by a former reg-
ulator and now a seed company executive, the early stages
of developing the Bt maize was a learning process for the
regulators that was enhanced by open communication
with the industry. Because Bt maize was the first GM crop
product, the regulators “were not really sure what exactly
they wanted to see or to evaluate to determine safety.”
Open communication between regulatory bodies and pri-
vate companies was therefore a “big factor that added to
building trust,” which in turn led to better compliance to
the regulatory process.
Once the requirements for regulatory approval are
clearly communicated, it is important that the private
sector fully discloses all information necessary so that the
regulators can make decisions about the technology. The
government needs to be able to trust that the private sec-
tor will “give accurate information, truthful information,
not withhold the information that could impact their
decision. And to comply with any conditions that have
been given.” In return, the private sector must feel
assured that the government will maintain confidentiality
on all sensitive product information.
The mutual trust built between the regulator and indus-
try has led to enhanced communication and consultation
between them. For example, an interviewee from the seed
industry noted that, when lobbyists or anti-GMO organi-
zations lodge a complaint against Bt maize technology, the
government trusts the private sector enough to approach
them by “say[ing] that ‘this is an accusation that came in
pertaining to your products, what information can you give
us?’” This positive relationship was enabled by mutual
trust between the regulatory bodies and private sector
stakeholders.
4. Good agronomic practices sow success and foster trust
Another important issue related to trust was the uphold-
ing of good agronomic practices by the farmers when
growing Bt maize. Good agronomic practices include the
distancing of GM and non-GM crops physically and tem-
porally, and planting refuge areas in order to prevent
insect resistance build-up to transgenic crops such as Bt
maize [17]. Refuge areas, or refugia, are the buffer zones of
non-Bt maize (susceptible to stalk borers) planted in close
proximity to Bt maize to provide a pool of stalk borers
susceptible to Bt maize. This is meant to delay develop-
ment of resistance to the toxic protein produced by Bt
[18]. As South Africa was the first African country to
report stem borer resistance to the Bt toxin, the need to
ensure a proper refuge area is becoming more important.
Many interviewees (including farmers, industry and gov-
ernment executives) emphasized the importance of plant-
ing Bt maize correctly and particularly underlined the
importance of enforcing the planting of the refuge area
between conventional and Bt maize.
Farmer interviewees attributed positive trust-building
experiences to good agronomic practices: number one, we
planted exactly the way they [the seed company] said.
They taught us how to plant and we did exactly what they
said. And then they told us that we must de-weed every
time we see the weeds coming out. And we did exactly
what they said… that’s why our maize was so beautiful.
Enforcing these agronomic practices is not only beneficial
to the farmer but also to the companies selling the tech-
nology. As an interviewee from a seed company described:
We want to make sure that they [farmers] also plant the
refugia, and that they abide by the rules. It’s of interest to
all of us. Refugia is not something to make it difficult; it’s
there to protect the traits. We want it to be protected for as
long as possible.
Failure to enforce the refuge area, on the part of both
farmers and the private sector, was cited as a challenge
to building trust. Some farmers chose not to plant a
refuge area due to their desire to maximize profits per
unit area. They said they were hesitant to reserve a por-
tion of their fields for a refuge area of conventional
maize, which would produce lower yields compared to
Bt maize and, in turn, lead to reduced profit. Moreover,
other farmer interviewees recalled that some seed com-
panies fail to enforce the refuge area by neither educat-
ing their customers about the need to plant nor monitor
it. One farmer stated, “they [seed companies] don’t pro-
mote the refugia areas enough,” and each time the seed
company sold seeds to him, he would ask, “’but what
about my maize for my refugia area?’” He further stated:
They don’t tell you that if you’re going to buy 100 bags,
95 bags must be Bt and 5 bags must be for your refugia
area. What ensues from industry member’s failure to
ensure appropriate management of the refuge area is
the erosion of trust between the farmer and the private
sector. While the private sector companies are hesitant
to trust farmers to use proper agronomic practices,
some farmers cannot trust seed distributors to ade-
quately promote and provide the necessary conventional
maize to plant their refuge area. In order to maintain
trust and protect the effectiveness of the Bt maize tech-
nology, it is critical that both farmers and the private
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sector work together to enforce and monitor proper
agronomic practices.
Conclusions
The success of the Bt maize project in South Africa has
been, and will continue to be, dependent upon the
concerted effort of the farmers; government; and private
sector stakeholders to establish and maintain trust. The
four key lessons on trust building that were drawn from
this case study can be applied to other agbiotech PPPs
attempting to successfully introduce GM technology in
sub-Saharan Africa. Each of the trust-building practices
described in this case study require collaboration among
stakeholders, though most can be undertaken without sub-
stantial financial inputs from any one partner. In interac-
tions between the government and the private sector,
transparency; accountability; and open communication are
critical for navigating the regulatory process. When estab-
lishing trust with farmers, it is essential that the private
sector be open and candid about both the benefits and
limitations of their technology. This should include infor-
mation sharing and awareness-building practices, such as
the on-farm demonstrations described in this study. To
maintain this mutual trust, farmers should also endeavor
to employ the technology responsibly and uphold proper
management practices, such as planting a refuge area.
Each of the practices and principles presented in this case
study has been shown to be essential for trust building in
the context of the Bt maize project in South Africa. If
applied with concerted effort, the key lessons presented in
this study can provide a roadmap for budding agbiotech
PPPs in designing their strategy for building trust with
farmers and ensuring the successful adoption of their
technology.
Additional material
Additional file 1: Key collaborators/partners in the Bt maize
partnership in South Africa.
Additional file 2: Sample interview questions.
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